Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Coates

Showing results (531-540 of 575) with videos related to

Pageof 58
Sort By:
Lancet (London, England)|December 10, 2022
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)Joseph F Merola, Robert Landewé, Iain B McInnes, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual MeetingRichard Holland, William Tillett, Alexis Ogdie, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working GroupYing Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology|May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working GroupAlexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology|March 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working GroupYing Ying Leung, Ana-Maria Orbai, William Tillett, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 15, 2020
Unconditional Care in Academic Emergency DepartmentsJeffrey A Kline, John H Burton, Christopher R Carpenter, et al.
The Plant Journal : for Cell and Molecular Biology|November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patensNoe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.
The Journal of Rheumatology|December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical TrialsAna-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
Joint Bone Spine|December 18, 2022
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countriesMarlene Sousa, Ennio Lubrano, Josef S Smolen, et al.
Arthritis Care & Research|February 27, 2020
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status?Laura C Coates, Xenofon Baraliakos, Francisco J Blanco, et al.
Pageof 58

Showing results (531-540 of 575) with videos related to

Sort By:
Pageof 58
Lancet (London, England)|December 10, 2022
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)Joseph F Merola, Robert Landewé, Iain B McInnes, et al.
The Journal of Rheumatology. Supplement|June 3, 2018
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual MeetingRichard Holland, William Tillett, Alexis Ogdie, et al.
The Journal of Rheumatology. Supplement|June 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working GroupYing Ying Leung, Ana-Maria Orbai, William Tillett, et al.
The Journal of Rheumatology|May 3, 2017
Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working GroupAlexis Ogdie, Maarten de Wit, Kristina Callis Duffin, et al.
The Journal of Rheumatology|March 2, 2021
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working GroupYing Ying Leung, Ana-Maria Orbai, William Tillett, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|May 15, 2020
Unconditional Care in Academic Emergency DepartmentsJeffrey A Kline, John H Burton, Christopher R Carpenter, et al.
The Plant Journal : for Cell and Molecular Biology|November 13, 2019
PEATmoss (Physcomitrella Expression Atlas Tool): a unified gene expression atlas for the model plant Physcomitrella patensNoe Fernandez-Pozo, Fabian B Haas, Rabea Meyberg, et al.
The Journal of Rheumatology|December 17, 2018
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical TrialsAna-Maria Orbai, Richard Holland, Ying Ying Leung, et al.
Joint Bone Spine|December 18, 2022
Patient-defined flares and disease activity worsening in 222 patients with psoriatic arthritis from 14 countriesMarlene Sousa, Ennio Lubrano, Josef S Smolen, et al.
Arthritis Care & Research|February 27, 2020
The Phenotype of Axial Spondyloarthritis: Is It Dependent on HLA-B27 Status?Laura C Coates, Xenofon Baraliakos, Francisco J Blanco, et al.
Pageof 58